Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 3
1988 3
1989 1
1990 2
1991 1
1992 1
1993 2
1994 1
1996 2
1998 3
1999 4
2000 3
2001 5
2002 4
2003 4
2004 5
2005 6
2006 1
2007 3
2008 7
2009 5
2010 8
2011 5
2012 5
2013 1
2014 1
2015 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Rosenstock J, Bajaj HS, Janež A, Silver R, Begtrup K, Hansen MV, Jia T, Goldenberg R; NN1436-4383 Investigators. Rosenstock J, et al. N Engl J Med. 2020 Nov 26;383(22):2107-2116. doi: 10.1056/NEJMoa2022474. Epub 2020 Sep 22. N Engl J Med. 2020. PMID: 32960514 Clinical Trial.
Lung cancer in women.
Pauk N, Kubík A, Zatloukal P, Krepela E. Pauk N, et al. Among authors: zatloukal p. Lung Cancer. 2005 Apr;48(1):1-9. doi: 10.1016/j.lungcan.2004.10.009. Epub 2004 Dec 13. Lung Cancer. 2005. PMID: 15777966 Review.
Gemcitabine in non-small cell lung cancer (NSCLC).
Manegold C, Zatloukal P, Krejcy K, Blatter J. Manegold C, et al. Among authors: zatloukal p. Invest New Drugs. 2000 Feb;18(1):29-42. doi: 10.1023/a:1006327729228. Invest New Drugs. 2000. PMID: 10830139 Review.
[The TULUNG clinical registry].
Spelda S, Skřičková J, Bortlíček Z, Hejduk K, Pešek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Tomíšková M, Grygárková Y, Havel L, Hrnčiarik M, Zemanová M, Sixtová D, Roubec J, Coupková H, Košatová K. Spelda S, et al. Among authors: zatloukal p. Klin Onkol. 2012;25(5):383-4. Klin Onkol. 2012. PMID: 23102201 Czech. No abstract available.
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R; European EGFR Workshop Group. Pirker R, et al. J Thorac Oncol. 2010 Oct;5(10):1706-13. doi: 10.1097/JTO.0b013e3181f1c8de. J Thorac Oncol. 2010. PMID: 20871269 Free article.
First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study.
Gatzemeier U, von Pawel J, Vynnychenko I, Zatloukal P, de Marinis F, Eberhardt WE, Paz-Ares L, Schumacher KM, Goddemeier T, O'Byrne KJ, Pirker R. Gatzemeier U, et al. Among authors: zatloukal p. Lancet Oncol. 2011 Jan;12(1):30-7. doi: 10.1016/S1470-2045(10)70278-3. Epub 2010 Dec 17. Lancet Oncol. 2011. PMID: 21169060 Clinical Trial.
[TARCEVA Clinical Registry].
Skricková J, Pesek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Krejcí J, Tomísková M, Grygárková Y, Havel L, Hrnciarik M, Skalová B, Stícha M. Skricková J, et al. Among authors: zatloukal p. Klin Onkol. 2010;23(5):361-3. Klin Onkol. 2010. PMID: 21061685 Czech. No abstract available.
83 results